Business · Companies · 1 hr ago
Swiss Biotech Windward Raises About $225 Million in US IPO
Swiss biotech Windward Bio Group AG raised about $225 million through a US initial public offering and a private placement.
An initial public offering, or IPO, is a sale of a company’s shares to public investors.
Windward’s IPO was priced at the midpoint of the range it had marketed.
The fundraising also included a private placement, a separate share sale.
The details given do not say how the company plans to use the money.
No next steps were specified.
Windward Bio Group AG raised about $225 million in a US initial public offering and private placement.
The IPO was priced at the midpoint of its marketed range.
Windward is a Swiss biotech company.
- Who
- Windward Bio Group AG.
- What
- It raised about $225 million in a US initial public offering and private placement.
- When
- November 12, 2026.
- Where
- The IPO was in the United States.
- Why
- Not stated.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Amount raised
- About $225 million
- Company
- Windward Bio Group AG
- IPO pricing
- Midpoint of its marketed range
- Fundraising
- US initial public offering and private placement